Thomas James Doyle - Net Worth and Insider Trading

Thomas James Doyle Net Worth

The estimated net worth of Thomas James Doyle is at least $851,349 dollars as of 2024-11-06. Thomas James Doyle is the SVP, Finance & Accounting of Kura Oncology Inc and owns about 48,593 shares of Kura Oncology Inc (KURA) stock worth over $851,349. Details can be seen in Thomas James Doyle's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas James Doyle has not made any transactions after 2024-01-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Thomas James Doyle

To

Thomas James Doyle Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas James Doyle owns 1 companies in total, including Kura Oncology Inc (KURA) .

Click here to see the complete history of Thomas James Doyle’s form 4 insider trades.

Insider Ownership Summary of Thomas James Doyle

Ticker Comapny Transaction Date Type of Owner
KURA Kura Oncology Inc 2024-01-29 SVP & Finance & Accounting

Thomas James Doyle Latest Holdings Summary

Thomas James Doyle currently owns a total of 1 stock. Thomas James Doyle owns 48,593 shares of Kura Oncology Inc (KURA) as of January 29, 2024, with a value of $851,349.

Latest Holdings of Thomas James Doyle

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KURA Kura Oncology Inc 2024-01-29 48,593 17.52 851,349

Holding Weightings of Thomas James Doyle


Thomas James Doyle Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas James Doyle has made a total of 2 transactions in Kura Oncology Inc (KURA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Kura Oncology Inc is the sale of 2,318 shares on January 29, 2024, which brought Thomas James Doyle around $41,260.

Insider Trading History of Thomas James Doyle

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas James Doyle Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas James Doyle Ownership Network

Ownership Network List of Thomas James Doyle

No Data

Ownership Network Relation of Thomas James Doyle

Insider Network Chart

Thomas James Doyle Owned Company Details

What does Kura Oncology Inc do?

Who are the key executives at Kura Oncology Inc?

Thomas James Doyle is the SVP & Finance & Accounting of Kura Oncology Inc. Other key executives at Kura Oncology Inc include Chief Legal Officer Teresa Brophy Bair , Chief Medical Officer Stephen Dale , and Chief Operating Officer Kathleen Ford .

Kura Oncology Inc (KURA) Insider Trades Summary

Over the past 18 months, Thomas James Doyle made 1 insider transaction in Kura Oncology Inc (KURA) with a net sale of 2,318. Other recent insider transactions involving Kura Oncology Inc (KURA) include a net sale of 4,668 shares made by Teresa Brophy Bair , a net sale of 91,052 shares made by Troy Edward Wilson , and a net purchase of 50,000 shares made by Thomas Malley .

In summary, during the past 3 months, insiders sold 0 shares of Kura Oncology Inc (KURA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 111,517 shares of Kura Oncology Inc (KURA) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 61,517 shares.

Kura Oncology Inc (KURA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kura Oncology Inc Insider Transactions

No Available Data

Thomas James Doyle Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas James Doyle. You might contact Thomas James Doyle via mailing address: C/o Kura Oncology, Inc., 12730 High Bluff Drive, Suite 400, San Diego Ca 92130.